Clinical implementation of noninvasive prenatal testing among maternal fetal medicine specialists
- 22 December 2013
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 34 (5) , 416-423
- https://doi.org/10.1002/pd.4301
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Cell-free fetal DNA testing: who is driving implementation?Genetics in Medicine, 2013
- Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA SequencingObstetrics & Gynecology, 2012
- DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative studyGenetics in Medicine, 2012
- Selective analysis of cell‐free DNA in maternal blood for evaluation of fetal trisomyPrenatal Diagnosis, 2012
- Noninvasive prenatal diagnosis: pregnant women's interest and expected uptakePrenatal Diagnosis, 2011
- Cell‐free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementationPrenatal Diagnosis, 2011
- Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA SequencingPLOS ONE, 2011
- Screening for Down syndrome: changing practice of obstetriciansAmerican Journal of Obstetrics and Gynecology, 2009
- Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasmaProceedings of the National Academy of Sciences, 2008
- The timing of elective delivery in preterm premature rupture of the membranes: a survey of Members of the Society of Maternal-Fetal MedicineAmerican Journal of Obstetrics and Gynecology, 2004